Some pharmacists are pushing back on Surescripts’ partnership with GoodRx, arguing the deal will hurt independent pharmacies and further obscure the high cost of drugs.
“The deal was touted as a move towards transparency; when in fact, coupon programs are bought and paid for by the same PBM [pharmacy benefit manager]-based, opaque pricing schema the deal claims to upend,” wrote a group of...
Pear Therapeutics' reSET-O, a prescription app for treating opioid use disorder, may lower patients’ health care costs, compared with patients who don’t use the app, according to a study published in the journal Hospital Practice.
“Engagement and continued treatment with reSET-O in patients with OUD treated with buprenorphine is associated with substantial real-world reductions in medical costs...
A recent mathematical simulation model found that, compared to other insomnia interventions like group cognitive behavioral therapy or pharmacotherapy, digital CBT delivered via Big Health's Sleepio was more cost-effective due to lower expenditures.
The research was funded by Big Health, and conducted by researchers from Johns Hopkins, the University of California, San Francisco, and the digital...
Implementation of either an automated or semi-automated deep learning system for diabetic retinopathy screening could lead to cost savings at the health-system level, according to an economic analysis modeling study recently published in The Lancet Digital Health.
Backed by Singapore's Ministry of Health, the investigation looked at data from a national diabetic retinopathy screening program...
For health plans and employers, one of the key attractions of telehealth is the potential savings involved in replacing physician office and emergency department visits with less expensive virtual visits. But new findings published in the journal Health Affairs suggest that telehealth may increase overall healthcare spending by increasing utilization.
In fact, in looking at commercial claims data...
